Cite
HARVARD Citation
Zhang, L. et al. (2022). Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study. Journal of gastroenterology and hepatology. 37 (5), pp. 823-831. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, L. et al. (2022). Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study. Journal of gastroenterology and hepatology. 37 (5), pp. 823-831. [Online].